# Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer

> **NCT04638036** · PHASE1 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 11 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Cetuximab-IRDye800
- **DEVICE:** Fluorescent molecular endoscopy and surgery

## Key facts

- **NCT ID:** NCT04638036
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-13
- **Primary completion:** 2022-01-28
- **Final completion:** 2023-05-21
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04638036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04638036, "Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04638036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*